APA (7th ed.) Citation

S, F., A, R., J, B., JS, C., Y, R., L, S., . . . MA, R. (2026). Real-world emergence of nirsevimab resistance in breakthrough infections with respiratory syncytial virus-B: A multicentre observational study in France. The Lancet. Microbe, 7(7), 101353. https://doi.org/10.1016/j.lanmic.2026.101353

Chicago Style (17th ed.) Citation

S, Fourati, et al. "Real-world Emergence of Nirsevimab Resistance in Breakthrough Infections with Respiratory Syncytial Virus-B: A Multicentre Observational Study in France." The Lancet. Microbe 7, no. 7 (2026): 101353. https://doi.org/10.1016/j.lanmic.2026.101353.

MLA (9th ed.) Citation

S, Fourati, et al. "Real-world Emergence of Nirsevimab Resistance in Breakthrough Infections with Respiratory Syncytial Virus-B: A Multicentre Observational Study in France." The Lancet. Microbe, vol. 7, no. 7, 2026, p. 101353, https://doi.org/10.1016/j.lanmic.2026.101353.